Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Ajou University Hospital, Suwon, Gyeonggido, Korea, Republic of
Ayşegül Çiğdem Çağlayan, Kocaeli, Turkey
Eunah Cho, Seoul, Korea, Republic of
Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Beijing Shijitan Hospital, Beijing, Beijing, China
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Medical University of Vienna, Vienna, Austria
Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China
Faculty Hospital Kralovske Vinohrady, Praha, Czechia
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes., Damanhūr, Elbehairah, Egypt
Demikhov Municipal Clinical Hospital 68, Moscow, Russian Federation
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.